Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR1 | P21554 | 2/20 | 0.73 |
| ▸ | CNR2 | P34972 | 2/20 | 0.73 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.73 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22028069 | 1.00 | CNR1 (0.73) | CNR1CNR2TDP1 | |
| SCHEMBL29380801 | 1.00 | CNR1 (0.73) | CNR1CNR2TDP1 | |
| SCHEMBL14578461 | 0.89 | CNR1 (0.76) | CNR1CNR2TDP1 | |
| SCHEMBL3452092 | 0.88 | CNR1 (0.75) | CNR1CNR2TDP1 | |
| SCHEMBL29361364 | 0.87 | CNR1 (0.70) | CNR1CNR2 | |
| SCHEMBL9302415 | 0.87 | CNR1 (0.70) | CNR1CNR2 | |
| SCHEMBL2909334 | 0.86 | CNR1 (0.71) | CNR1CNR2TDP1 | |
| SCHEMBL2030690 | 0.85 | CNR1 (1.00) | CNR1CNR2TDP1 | |
| SCHEMBL29835942 | 0.85 | CNR1 (1.00) | CNR1CNR2TDP1 | |
| SCHEMBL2030692 | 0.85 | CNR1 (1.00) | CNR1CNR2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4247362-A1 | FORMULATIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE | Anebulo Pharmaceuticals, Inc. (US) | 2023-09-27 | — | — | EP | disclosed |
| WO-2022109043-A1 | FORMULATIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE | ANEBULO PHARMACEUTICALS, INC. (US) | 2022-05-27 | — | — | WO | disclosed |
| EP-3986396-A1 | COMPOSITIONS AND METHODS FOR TREATING ACUTE CANNABINOID OVERDOSE WITH A CANNABINOID RECEPTOR ANTAGONIST | Opiant Pharmaceuticals, Inc. (US) | 2022-04-27 | — | — | EP | disclosed |